Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Henry

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trialD W Northfelt, B J Dezube, J A Thommes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.
Annals of Internal Medicine|May 15, 1993
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapyM A Fischl, R M Olson, S E Follansbee, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2015
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristicsA Lipton, K Fizazi, A T Stopeck, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapyD H Henry, B J Brooks, D C Case, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesF Saad, J E Brown, C Van Poznak, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trialD W Northfelt, B J Dezube, J A Thommes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.
Annals of Internal Medicine|May 15, 1993
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapyM A Fischl, R M Olson, S E Follansbee, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2015
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristicsA Lipton, K Fizazi, A T Stopeck, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapyD H Henry, B J Brooks, D C Case, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesF Saad, J E Brown, C Van Poznak, et al.
Pageof 4